{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:39:10Z","timestamp":1791394750625,"version":"4.3.3"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T00:00:00Z","timestamp":1235433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:italic>J. Neurochem<\/jats:italic>. (2009) <jats:bold>109<\/jats:bold>, 826\u2013837.<\/jats:p><\/jats:sec><jats:sec><jats:title>Abstract<\/jats:title><jats:p>Nicotine reduces dopaminergic deficits in parkinsonian animals when administered before nigrostriatal damage. Here we tested whether nicotine is also beneficial when given to rats and monkeys with pre\u2010existing nigrostriatal damage. Rats were administered nicotine before and after a unilateral 6\u2010hydroxydopamine lesion of the medial forebrain bundle, and the results compared with those in which rats received nicotine only after lesioning. Nicotine pre\u2010treatment attenuated behavioral deficits and lessened lesion\u2010induced losses of the striatal dopamine transporter, and \u03b16\u03b22* and \u03b14\u03b22* nicotinic receptors (nAChRs). By contrast, nicotine administered 2\u2003weeks after lesioning, when 6\u2010hydroxydopamine\u2010induced neurodegenerative effects are essentially complete, did not improve these same measures. Similar results were observed in 1\u2010methyl\u20104\u2010phenyl\u20101,2,3,6\u2010tetrahydropyridine\u2010lesioned monkeys. Nicotine did not enhance striatal markers when administered to monkeys with pre\u2010existing nigrostriatal damage, in contrast to previous data that showed improvements when nicotine was given to monkeys before lesioning. These combined findings in two animal models suggest that nicotine is neuroprotective rather than neurorestorative against nigrostriatal damage. Receptor studies with <jats:sup>125<\/jats:sup>I\u2010\u03b1\u2010conotoxinMII and the \u03b1\u2010conotoxinMII analog E11A were next performed to determine whether nicotine treatment pre\u2010 or post\u2010lesioning differentially affected expression of \u03b16\u03b14\u03b22* and \u03b16(non\u03b14)\u03b22* nAChR subtypes in striatum. The observations suggest that protection against nigrostriatal damage may be linked to striatal \u03b16\u03b14\u03b22* nAChRs.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1471-4159.2009.06011.x","type":"journal-article","created":{"date-parts":[[2009,2,25]],"date-time":"2009-02-25T03:36:58Z","timestamp":1235533018000},"page":"826-837","source":"Crossref","is-referenced-by-count":76,"title":["Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys"],"prefix":"10.1111","volume":"109","author":[{"given":"Luping Z.","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraja","family":"Parameswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuja","family":"Bordia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Michael McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryka","family":"Quik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,7]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/10298420290015863"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199912160-00034"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(99)00266-1"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2004.01.002"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.106997"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.035998"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.01640.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1998.00285.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(99)00294-8"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn877"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)03087-0"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.04.006"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj070486"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2003.09.014"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.05.023"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.07.032"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)90092-3"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.006429"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.05011.x"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2006.08.011"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0441-0"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2002.7900"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.09.008"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02482.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568007023339166"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.108.048843"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.121228"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.2741\/2695"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(00)00235-5"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00767-4"},{"key":"e_1_2_7_33_1","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1523\/JNEUROSCI.21-15-05494.2001","article-title":"Vulnerability of 125I\u2010alpha\u2010conotoxin MII binding sites to nigrostriatal damage in monkey","volume":"21","author":"Quik M.","year":"2001","journal-title":"J. Neurosci."},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.5.1169"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.006015"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0215-06.2006"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04078.x"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.06.015"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2007.03.001"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.7.990"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703989"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.65.6.1526"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2004.02347.x"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2006.11.009"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(02)01070-5"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050818"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000256374.50227.4b"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30555"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608715103"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2006.04.015"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0055-04.2004"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2009.06011.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.2009.06011.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T20:28:17Z","timestamp":1696969697000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2009.06011.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,7]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1471-4159.2009.06011.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06011.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,7]]}}}